Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Debt / NOTE 1.750% 6/1
-
Market price (% of par)
-
158.88%
-
Total 13F principal
-
$532,616,124
-
Principal change
-
+$10,695,124
-
Total reported market value
-
$845,206,245
-
Number of holders
-
51
-
Value change
-
+$20,434,352
-
Number of buys
-
23
-
Number of sells
-
24
Institutional Holders of IONIS PHARMACEUTICALS INC - NOTE 1.750% 6/1 as of Q4 2025
As of 31 Dec 2025,
IONIS PHARMACEUTICALS INC - NOTE 1.750% 6/1 was held by
51 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$532,616,124
in principal (par value) of the bond.
The largest 10 bondholders included
VOYA INVESTMENT MANAGEMENT LLC, DEERFIELD MANAGEMENT COMPANY, L.P., CAMDEN ASSET MANAGEMENT L P /CA, TWO SIGMA INVESTMENTS, LP, Balyasny Asset Management L.P., LMR Partners LLP, DLD Asset Management, LP, Linden Advisors LP, WELLINGTON MANAGEMENT GROUP LLP, and BlackRock, Inc..
This page lists
51
institutional bondholders reporting positions
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.